Avian influenza

Backyard Chicken Company Experiencing Soaring Sales Due to Increased Egg Prices

Retrieved on: 
Monday, January 23, 2023
Chicken, Egg, Poultry, Food security, Employment, Avian influenza, Education, Poultry farming

BROOKS, Ga., Jan. 23, 2023 /PRNewswire/ -- Following the widespread Avian Flu outbreak and increased price of eggs in the US, mypetchicken.com has seen record-breaking sales numbers in January 2023, trending 2-3 times over last year with no signs of slowing down. A growing concern about food security is the primary driving factor behind first-time customers purchasing backyard chickens. Experienced chicken keepers are also adding to their flocks to increase egg production, and meet demand for their communities.

Key Points: 
  • A growing concern about food security is the primary driving factor behind first-time customers purchasing backyard chickens.
  • Experienced chicken keepers are also adding to their flocks to increase egg production, and meet demand for their communities.
  • As more people begin their journey with backyard poultry, My Pet Chicken has increased its team to provide the highest level of customer service support and education in the industry.
  • The company recently launched a new, user-friendly website that allows customers to filter for breeds based on desired characteristics, such as egg color and laying rate.

CAST Releases a Special Publication on "Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective"

Retrieved on: 
Monday, November 14, 2022
Zoonosis, Animal, University, Occupational safety and health, Nipah virus, Health, Michigan State University, Environment, USDA, United States environmental and occupational health in zoos, Library, Knowledge, MERS, Livestock, Water, Organization, Q&A, National Center for Immunization and Respiratory Diseases, Biophysical environment, Avian influenza, Ohio State University, Agricultural science, Center, Private sector, Investment, Environmental science, Centers for Disease Control and Prevention, George Washington University, Veterinary medicine, COVID-19, Poultry, Human, College of Arts and Sciences, CAST, Thought, Pandemic, Public health, Agricultural Research Service, Food, Emerging, Council, Agriculture, Engineering, Milken Institute School of Public Health, SARS, Medicine, AMES

AMES, Iowa, Nov. 14, 2022  /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology's (CAST) new paper, Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective, is now available for free download.

Key Points: 
  • AMES, Iowa, Nov. 14, 2022 /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology's (CAST) new paper, Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective, is now available for free download .
  • One Health brings together experts and thinking in biomedicine and health, but goes much further to include animal, environmental, climate sciences, social and behavioral sciences, agriculture, business, engineering, and many more fields.
  • Zoonotic diseases are diseases of animals that infect humans and continue to afflict humanity and animal health and welfare.
  • The special publication, Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective, is available to download on CAST's website.

Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year”

Retrieved on: 
Thursday, November 3, 2022
Health, Medical Devices, Infectious Diseases, Research, Science, Pharmaceutical, Biotechnology, Public health, United States Department of Agriculture, RNA, Severe acute respiratory syndrome coronavirus 2, Leadership, DNA, Government, Animal, Pandemic, NA, LLC, Department of Biotechnology, Biopharma LLC, Food, Tuberculosis, Temperature, Biotechnology, RSV, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Solution, Monkeypox, Human, Department of Human Services and Health, FDA, HA, Health care, Health, TB, Epitope, Therapy, Vaccine, COVID-19, Collection, Peptide, Infection, Avian influenza, African swine fever virus, Laboratory, Mycobacterium tuberculosis, Program, MTM, Fine chemical, Avian, Longhorn, Genomics, Diagnosis

Longhorn Vaccines & Diagnostics , a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced it has been named Diagnostics Company of the Year in the second annual BioTech Breakthrough Awards program.

Key Points: 
  • Longhorn Vaccines & Diagnostics , a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced it has been named Diagnostics Company of the Year in the second annual BioTech Breakthrough Awards program.
  • Our goal is to improve the delivery of molecular diagnostics to serve critical unmet needs in both the developed and developing world, said Longhorn Vaccines and Diagnostics President Jeff Fischer.
  • We offer a heartfelt congratulations on being our choice for Diagnostics Company of the Year!
  • Longhorn Vaccines and Diagnostics LLC is a One Health and One World company based in Maryland that is developing vaccines and diagnostic tools for worldwide public health concerns and to prevent future pandemics.

The Worldwide Off-Highway Vehicle Telematics Industry is Expected to Reach $1 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 21, 2022
Aftermarket, Automotive, Technology, Satellite, Telecommunications, Fleet Management, CAGR, Organization, SARS, GPS, Transport, Growth, Compliance, Mining, ELD, Health, Data analysis, Agriculture, Industry, Safety, OHV, Time, COVID-19, Avian influenza, Union, Solution, Eldes Corner, Minnesota, Maintenance, Severe acute respiratory syndrome coronavirus 2, Technology, Vehicle, Satellite navigation device, Road

The global off-highway vehicle telematics market was valued at US$ 754.44 million in 2020 and is expected to reach US$ 1,166.96 million by 2028; it is estimated to register a CAGR of 5.9% during the forecast period.

Key Points: 
  • The global off-highway vehicle telematics market was valued at US$ 754.44 million in 2020 and is expected to reach US$ 1,166.96 million by 2028; it is estimated to register a CAGR of 5.9% during the forecast period.
  • Telematics hardware and software solutions for remote monitoring and management of fleets of machinery and equipment used in these industries are called off-highway vehicle telematics.
  • By using off-highway vehicle (OHV) telematics devices that allow GPS, cellular, or satellite connectivity for access to real-time equipment data, off-highway vehicle telematics solutions offer continuous monitoring of the position, condition, health, and utilization of equipment.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global off-highway vehicle telematics market.

Zoetis Named One of Most Innovative Companies in 2022 by Fast Company

Retrieved on: 
Wednesday, March 9, 2022
Infectious Diseases, Health, Veterinary, Other Health, Avian influenza, OIE, San Diego Zoo Safari Park, San Diego Zoo Wildlife Alliance, Livestock, Sustainability reporting, Risk, United States Department of Agriculture, Farmer, Chief sustainability officer, Safari park, Annual report, ESG, World Organization of Family Doctors, Communication, Research, Most, Culture, Human, Corporate Affairs, Health, San Diego, Infection, USDA, World, Foot, Doctor of Philosophy, Hendra virus, Rabies, Center, Porcine epidemic diarrhea virus, Solution, African swine fever virus, WHO, COVID-19, Lion, Tiger, Severe acute respiratory syndrome coronavirus 2, Lyme disease, Organization, Veterinarian, Goal, Vaccine, Forward-looking statement, Animal, Zoetis, West Nile virus

Zoetis has been named to Fast Companys list of Most Innovative Companies for 2022 , ranking eighth in the corporate social responsibility category.

Key Points: 
  • Zoetis has been named to Fast Companys list of Most Innovative Companies for 2022 , ranking eighth in the corporate social responsibility category.
  • In addition to the World's 50 Most Innovative Companies, 528 organizations are recognized across 52 categories.
  • In other recognitions of its progress on sustainability, Zoetis was named one of Newsweeks Most Responsible Companies for 2022 and was included in Investors Business Dailys 100 Best ESG Companies .
  • All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.

Animal Biotechnology Market Size to grow by USD 3.26 billion | 51% of the market's growth to originate from North America| 17,000+ Technavio Reports

Retrieved on: 
Monday, February 21, 2022
FREE, FMD, Salmonella, Growth, Animal, Prevalence, Awareness, Driver, Bovine respiratory disease, Vaccine, BRD, USD, Biotechnology, African swine fever virus, Foot, Student, Avian influenza, Medicine, Teen Driver Challenge, Degenerative disease, Time, Marketing, Fine chemical

North America held the largest animal biotechnology market share in 2021.

Key Points: 
  • North America held the largest animal biotechnology market share in 2021.
  • Furthermore, countries such as Germany, China, Canada, and UK are expected to emerge as prominent markets for animal biotechnology market during the forecast period.
  • In addition, the increasing prevalence of animal diseases will also influence the market's growth positively during the forecast period.
  • Download free sample for highlights on market Drivers & Challenges affecting the animal biotechnology market.

Tyson Foods: Outpacing a Growing, Global Protein Market

Retrieved on: 
Thursday, December 9, 2021
XXV, Exercise, Agriculture, Failure, Efficiency, 100,000, Lists of disasters, State, Policy, Food safety, XV, TSN, Acquisition, Compliance, Environment, Natural Resources, GLOBE, Tyson Foods, Health, Avian influenza, Bovine spongiform encephalopathy, Automation, Vii, Private Securities Litigation Reform Act, Industry, Bioterrorism, Xi, Trade, Intellectual property, Public expenditure, Marketing, Artificial intelligence, U.S. Securities and Exchange Commission, NYSE, Farmer, Company, Culture, Growth, Security (finance), Animal, Weather, Pandemic, Plant, Livestock, African swine fever virus, Core values, Advertising, BSE, COVID-19 vaccine, Time, COVID-19, ASF, Management, Oil, Risk management

Chairman John H. Tyson, President and CEO Donnie King and members of the companys senior leadership team spoke at the event.

Key Points: 
  • Chairman John H. Tyson, President and CEO Donnie King and members of the companys senior leadership team spoke at the event.
  • By focusing on our product portfolio and by adding capacity to meet demand, we expect to outpace the market.
  • Tyson Foods is targeting volume growth ahead of the market in every segment.
  • Tyson Foods, Inc. (NYSE: TSN) is one of the worlds largest food companies and a recognized leader in protein.

Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021

Retrieved on: 
Thursday, April 29, 2021
Animal virology, Veterinary medicine, Health sciences, Medicine, Avian influenza, Influenza A virus, Influenza, Orthomyxoviridae

b'DUBLIN, April 29, 2021 /PRNewswire/ -- The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com\'s offering.\nAvian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape.\nThe report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.

Key Points: 
  • b'DUBLIN, April 29, 2021 /PRNewswire/ -- The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com\'s offering.\nAvian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape.\nThe report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.
  • The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases.
  • Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.\nThe report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.\nThe report is built using data and information sourced from the publisher\' proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
  • Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.

Avian Influenza (Infectious Disease) Drugs in Development, 2021 Report - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 28, 2021
Infectious diseases, Pharmaceutical, Health, Animal virology, Agricultural health and safety, Avian influenza, Veterinary medicine, Influenza, Medical specialties, Health sciences

b'The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\nThe report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases.

Key Points: 
  • b'The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\nThe report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases.
  • Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.\nThe report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.\nThe report reviews pipeline therapeutics for Avian Influenza (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.\nThe report covers pipeline products based on various stages of development ranging from discovery till pre-registration.\nThe report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities.\nThe report reviews key players involved in the development of Avian Influenza (Infectious Disease) therapeutics and enlists all their major and minor projects.\nThe report assesses Avian Influenza (Infectious Disease) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\nThe report summarizes all the dormant and discontinued pipeline projects.\n'

Global Avian Influenza Clinical Trial Pipeline Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 30, 2021
Infectious diseases, Health, Clinical trials, Health sciences, Health, Clinical research, Pharmaceutical industry, Drug discovery, Agricultural health and safety, Animal virology, Avian influenza, Clinical trial, Influenza, Influenza pandemic, Influenza research

The "Global Avian Influenza Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Avian Influenza Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Avian Influenza Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Avian Influenza market.
  • It covers emerging therapies for Avian Influenza in active clinical development stages including early and late stage clinical trials.
  • The report provides Avian Influenza pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.